Chemoinformaics analysis of 1beta-Hydroxycostic acid
Molecular Weight | 250.338 | nRot | 2 |
Heavy Atom Molecular Weight | 228.162 | nRig | 14 |
Exact Molecular Weight | 250.157 | nRing | 2 |
Solubility: LogS | -2.404 | nHRing | 0 |
Solubility: LogP | 2.049 | No. of Aliphatic Rings | 2 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 42.1254 |
nHD | 2 | BPOL | 22.9386 |
QED | 0.585 |
Synth | 4.263 |
Natural Product Likeliness | 3.156 |
NR-PPAR-gamma | 0.025 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.019 |
CACO-2 | -5.205 |
MDCK | 0.000011 |
BBB | 0.103 |
PPB | 0.620856 |
VDSS | 0.308 |
FU | 0.361168 |
CYP1A2-inh | 0.043 |
CYP1A2-sub | 0.065 |
CYP2c19-inh | 0.016 |
CYP2c19-sub | 0.058 |
CYP2c9-inh | 0.06 |
CYP2c9-sub | 0.276 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.28 |
CYP3a4-inh | 0.013 |
CYP3a4-sub | 0.122 |
CL | 4.995 |
T12 | 0.733 |
hERG | 0.041 |
Ames | 0.136 |
ROA | 0.975 |
SkinSen | 0.382 |
Carcinogencity | 0.509 |
EI | 0.872 |
Respiratory | 0.963 |
NR-Aromatase | 0.815 |
Antiviral | Yes |
Prediction | 0.883229 |